CORTINOVIS, DIEGO LUIGI
CORTINOVIS, DIEGO LUIGI
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
An open-label, randomized phase III study of early switch maintenance vs delayed second-line nivolumab in advanced stage squamous non-small cell lung cancer (NSCLC) patients after standard first-line platinum-based chemotherapy-EDEN trial GOIRC 04–2016
2025 Gelsomino, F; Boni, L; Tiseo, M; Ricciardi, S; Rocco, D; Cortinovis, D; Proietto, M; Cogoni, A; Pasello, G; Camerini, A; Sperandi, F; Colantonio, I; Metro, G; Mazzoni, F; Baldini, E; Veccia, A; Bennicelli, E; Cecilia Bettini, A; Tognetto, M; Ardizzoni, A
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis
2025 Malighetti, F; Villa, M; Villa, A; Pelucchi, S; Aroldi, A; Cortinovis, D; Canova, S; Capici, S; Cazzaniga, M; Mologni, L; Ramazzotti, D; Cordani, N
Real-world outcomes of subsequent treatment strategies after durvalumab consolidation in stage III unresectable non-small cell lung cancer
2025 Crespi, V; Delcuratolo, M; Minuti, G; Montrone, M; Pilotto, S; Roca, E; Metro, G; Leonetti, A; Pelizzari, G; Genova, C; Olmetto, E; Cortinovis, D; Russo, A; Pasello, G; Bulotta, A; Grossi, F; Buosi, R; Conte, A; Sini, C; Greco, C; Morabito, A; Pignataro, D; Pagano, M; Gori, S; Giannarelli, D; Novello, S; Passiglia, F
The hype around ctDNA guiding an informed perioperative therapeutic strategy in early-stage non-small cell lung cancer
2025 Passarella, G; Canova, S; Abbate, M; Caspani, G; Sala, L; Russo, A; Muscolino, P; Colonese, F; Cortinovis, D
A cross-sectional analysis of treatment patterns in small-cell lung cancer in five European countries
2024 Reguart, N; Pérol, M; Cortinovis, D; Puntis, S; Öhrling, K; Archangelidi, O; Louie, K; Blackhall, F; Sebastian, M
Abstract 987: Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy
2024 Malighetti, F; Villa, M; Sala, E; Geeta, G; Arosio, G; Gemelli, M; Manfroni, C; Fontana, D; Cordani, N; Meneveri, R; Zambon, A; Piazza, R; Pagni, F; Cortinovis, D; Mologni, L
Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO)
2024 Pizzutilo, E; Agostara, A; Oresti, S; Signorelli, D; Stabile, S; Lauricella, C; Motta, V; Amatu, A; Ruggieri, L; Brambilla, M; Occhipinti, M; Proto, C; Giusti, R; Filetti, M; Genova, C; Barletta, G; Gelsomino, F; Bennati, C; Siringo, M; Di Fazio, G; Russano, M; Montrone, M; Gariazzo, E; Roca, E; Bordi, P; Delmonte, A; Scimone, A; Belluomini, L; Mazzoni, F; Carta, A; Pelizzari, G; Viscardi, G; Morgillo, F; Gelibter, A; Gori, S; Berardi, R; Cortinovis, D; Ardizzoni, A; Veronese, S; Sartore-Bianchi, A; Giannetta, L; Cerea, G; Siena, S
Alectinib in Early-Stage Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: Current Evidence and Future Challenges
2024 Cortinovis, D; Leonetti, A; Morabito, A; Sala, L; Tiseo, M
Colorectal Cancer Pulmonary Metastasectomy: When, Why and How
2024 Petrella, F; Danuzzo, F; Sibilia, M; Vaquer, S; Longarini, R; Guidi, A; Raveglia, F; Libretti, L; Pirondini, E; Cara, A; Cassina, E; Tuoro, A; Cortinovis, D
Economic assessment of NGS testing workflow for NSCLC in a healthcare setting
2024 Seminati, D; L'Imperio, V; Casati, G; Ceku, J; Pilla, D; Scalia, C; Gragnano, G; Pepe, F; Pisapia, P; Sala, L; Cortinovis, D; Bono, F; Malapelle, U; Troncone, G; Novello, S; Pagni, F
Emerging Treatment Options for Neuroendocrine Neoplasms of Unknown Primary Origin: Current Evidence and Future Perspectives
2024 Corti, F; Rossi, R; Cafaro, P; Passarella, G; Turla, A; Pusceddu, S; Coppa, J; Oldani, S; Guidi, A; Longarini, R; Cortinovis, D
Immunotherapy in Non-Small-Cell Lung Cancer: A Modified Delphi Survey Consensus on First Line Treatment, Special Populations and Rechallenge
2024 Colonese, F; Bulotta, A; Genova, C; Signorelli, D; Bonanno, L; Proto, C; Null, N; Cortinovis, D
Intratumoral Treatment in Lung Cancer: Is It Time to Move Towards Clinical Practice?
2024 Pagliari, G; Colonese, F; Canova, S; Abbate, M; Sala, L; Petrella, F; Clementi, T; Cortinovis, D
MET exon 14 skipping mutations in non-small-cell lung cancer: real-world data from the Italian biomarker ATLAS database
2024 Reale, M; Passiglia, F; Cappuzzo, F; Minuti, G; Occhipinti, M; Bulotta, A; Delmonte, A; Sini, C; Galetta, D; Roca, E; Pelizzari, G; Cortinovis, D; Gariazzo, E; Pilotto, S; Citarella, F; Bria, E; Muscolino, P; Pozzessere, D; Carta, A; Pignataro, D; Calvetti, L; Leone, F; Banini, M; Di Micco, C; Baldini, E; Favaretto, A; Malapelle, U; Novello, S; Pasello, G; Tiseo, M
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
2024 Spicer, J; Garassino, M; Wakelee, H; Liberman, M; Kato, T; Tsuboi, M; Lee, S; Chen, K; Dooms, C; Majem, M; Eigendorff, E; Martinengo, G; Bylicki, O; Rodriguez-Abreu, D; Chaft, J; Novello, S; Yang, J; Arunachalam, A; Keller, S; Samkari, A; Gao, S; Afanasyev, S; Ahmed, S; Alekshun, T; Alves, G; Anderson, I; Araujo, L; Arkhipov, A; Arora, A; Bai, J; Begin, P; Belonogov, A; Berard, H; Berceanu-Ion, R; Bernabe Caro, R; Bondarenko, I; Bonnet, R; Bosch Barrera, J; Brocca, C; Bryl, M; Bulotta, A; Calles Blanco, A; Carcereny, E; Carvalho, L; Cebotaru, C; Chaft, J; Charu, V; Chaves, F; Chen, J; Chen, H; Chen, Q; Chen, K; Chiang, C; Chiu, C; Cicenas, S; Ciubotaru, E; Ciuleanu, T; Ciurescu, I; Cobb, P; Coetzee, C; Collins, D; Cortinovis, D; Costas, K; Costin, D; Cronemberger, E; Cuevo, R; Cuffe, S; De Marchi, P; de Paiva Junior, T; Delmonte, A; Demedts, I; Deschepper, K; Dias, J; Duchemann, B; Dutra, C; Duvivier, H; Ernani, V; Faehling, M; Faria, L; Fedenko, A; Fernando, H; Ferrara, R; Ferrari, V; Finley, G; Fix, P; Flores, M; Fourie, S; Franke, F; Frohling, K; Furqan, M; Gal, C; Galamaga, R; Ganea, D; Ganti, A; Garassino, M; Gentzler, R; Gianni, L; Gilli, M; Girard, N; Goranov, B; Gregorc, V; Greystoke, A; Grisanti, S; Grohe, C; Guarino, M; Guimaraes, J; Guisier, F; Halmos, B; Hammoud, Z; Han, J; Hegmane, A; Heng, F; Horinouchi, H; Horio, Y; Hu, J; Huang, H; Hui, R; Ikeda, N; Intagliata, S; Iordan, I; Jacobs, C; Jain, K; Jain, S; Jiang, T; Karaseva, N; Kaywin, P; Kazmi, S; Keresztes, R; Khan, S; Kim, J; Kolesnik, O; Kolesnik, O; Kollmeier, J; Komiya, T; Koontz, M; Krasnohrud, Y; Kristedja, T; Kryzhanivska, A; Kuroda, H; Laktionov, K; Lambrechts, M; Lang, S; Langleben, A; Lehmann, M; Levchenko, E; Levenko, O; Li, S; Liao, B; Lima, I; Liu, G; Liu-Dumlao, T; Lo Russo, G; Lou, Y; Lowczak, A; Luft, A; Ma, S; Majem Tarruella, M; Makles, K; Martinengo, G; Martinez Marti, A; Matias, D; Mazieres, J; Mazilu, L; Mennecier, B; Migliorino, M; Misleh, J; Molina, J; Morbeck, I; Mueller, A; Muto, S; Nadal Alforja, E; Nesterova, A; Nishio, W; Niu, J; O'Brien, M; O'Day, S; Ogliari, F; Okada, M; Pang, Y; Paramonov, V; Pastor, A; Pawlak, I; Piantedosi, F; Pollock, T; Pope, T; Puig, J; Radhi, S; Rao, S; Rathnasabapathy, C; Reck, M; Reinacher-Schick, A; Rich, P; Ritgen, M; Rittmeyer, A; Roca, E; Rodriguez-Abreu, D; Ruff, P; Rybkin, I; Saji, H; Sakao, Y; Sangal, A; Santoro, A; Sardenberg, R; Savvides, P; Scheusan, R; Schiller, J; Schumacher, L; Serke, M; Shim, B; Shimizu, J; Shio, Y; Sibille, A; Siegel, R; Signorelli, D; Smagina, M; Sokur, I; Spicer, J; Srkalovic, G; Stampleman, L; Starodub, A; Stencel, K; Sugio, K; Surmont, V; Suzuki, H; Tabacof, J; Takamochi, K; Tan, L; Tanaka, F; Tatangelo, M; Tauscher, D; Teixeira, C; Thiberville, L; Trukhin, D; Tsai, C; Ungureanu, A; Ursol, G; Vanakesa, T; Vansteenkiste, J; Varela, M; Villalona-Calero, M; Villaruz, L; Vogel, G; Voitko, N; Wang, Q; Wang, W; Wang, C; Wang, S; Wehler, T; Weksler, B; Wermke, M; Wesseler, C; Wirtz, H; Wong, M; Yan, X; Yang, Y; Yu, K; Zasadny, X; Zemaitis, M; Zhang, L; Zhao, G; Zhao, Q; Zhu, Y; Zurawski, B
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients
2024 Villa, M; Malighetti, F; Sala, E; Sharma, G; Arosio, G; Gemelli, M; Manfroni, C; Fontana, D; Cordani, N; Meneveri, R; Zambon, A; Piazza, R; Pagni, F; Cortinovis, D; Mologni, L
Newest therapeutic strategies impacting on rarest thoracic malignancies: The clinical case report of biphasic pleural mesothelioma
2024 Pellicioli, F; Sala, L; Colonese, F; Belloni, E; Abbate, M; Canova, S; D'Agostino, A; Cortinovis, D
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma
2024 Szlosarek, P; Creelan, B; Sarkodie, T; Nolan, L; Taylor, P; Olevsky, O; Grosso, F; Cortinovis, D; Chitnis, M; Roy, A; Gilligan, D; Kindler, H; Papadatos-Pastos, D; Ceresoli, G; Mansfield, A; Tsao, A; O'Byrne, K; Nowak, A; Steele, J; Sheaff, M; Shiu, C; Kuo, C; Johnston, A; Bomalaski, J; Zauderer, M; Fennell, D
Pleural mesothelioma in situ: A comprehensive review
2024 Danuzzo, F; Raveglia, F; Spinelli, F; Sibilia, C; Cassina, E; Libretti, L; Pirondini, E; Tuoro, A; Bono, F; Paladino, M; Cortinovis, D; Petrella, F
Proteolysis Targeting Chimera Agents (PROTACs): New Hope for Overcoming the Resistance Mechanisms in Oncogene-Addicted Non-Small Cell Lung Cancer
2024 Cordani, N; Nova, D; Sala, L; Abbate, M; Colonese, F; Cortinovis, D; Canova, S